MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

What symbol and exchange does Mimedx Group shares trade?

Mimedx Group trades on the NASDAQ stock market under the symbol MDXG.

What is Mimedx Group stock price doing today?

As of October 23, 2026, MDXG stock price declined to $3.91 with 1,206,224 million shares trading.

What is Mimedx Group's Beta?

MDXG has a beta of 0.52, meaning it tends to be less sensitive to market movements. MDXG has a correlation of 0.03 to the broad based SPY ETF.

How much is Mimedx Group worth?

MDXG has a market cap of $570.60 million. This is considered a Small Cap stock.

How much money does Mimedx Group make?

Last quarter Mimedx Group reported $64 million in Revenue and -$.05 earnings per share. This beat revenue expectation by $902,000 and missed earnings estimates by -$.02.

What is the highest and lowest price Mimedx Group traded in the last 3 year period?

In the last 3 years, MDXG traded as high as $10.14 and as low as $3.03.

What are the top ETFs holding Mimedx Group?

The top ETF exchange traded funds that MDXG belongs to (by Net Assets): VTI, IWM, AVUV, XBI, VXF.

Is Mimedx Group (MDXG) a good investment?

MDXG has underperformed the market in the last year with a price return of -41.1% while the SPY ETF gained +14.3%. MDXG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.3% and -16.3%, respectively, while the SPY returned +3.2% and -2.4%, respectively.

What are the support and resistance levels for Mimedx Group (MDXG)?

MDXG support price is $3.80 and resistance is $4.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDXG shares will trade within this expected range on the day.